Assay Detail
Functional
CHEMBL3412337
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Cytotoxicity against human HepG2 cells assessed as surviving fraction ratio after 48 hrs by SRB assay relative to control
27
Total Activities
27
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | HepG2 |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 27 | 4.49 | 4.96 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL3409822 | — | — | 1 | 4.96 |
| CHEMBL3409820 | — | — | 1 | 4.66 |
| CHEMBL3409819 | — | — | 1 | 4.63 |
| CHEMBL3409817 | — | — | 1 | 4.59 |
| CHEMBL3409823 | — | — | 1 | 4.59 |
| CHEMBL3409816 | — | — | 1 | 4.58 |
| CHEMBL3407524 | — | — | 1 | 4.58 |
| CHEMBL3409815 | — | — | 1 | 4.55 |
| CHEMBL3409829 | — | — | 1 | 4.52 |
| CHEMBL3409824 | — | — | 1 | 4.50 |
| CHEMBL3409825 | — | — | 1 | 4.50 |
| CHEMBL1414013 | — | — | 1 | 4.45 |
| CHEMBL1718425 | — | — | 1 | 4.45 |
| CHEMBL53463 | DOXORUBICIN | 4.0 | 1 | 4.44 |
| CHEMBL3409836 | — | — | 1 | 4.44 |
| CHEMBL3409818 | — | — | 1 | 4.43 |
| CHEMBL3409821 | — | — | 1 | 4.42 |
| CHEMBL3409827 | — | — | 1 | 4.41 |
| CHEMBL3409828 | — | — | 1 | 4.36 |
| CHEMBL3409831 | — | — | 1 | 4.35 |
| CHEMBL3409834 | — | — | 1 | 4.34 |
| CHEMBL3409835 | — | — | 1 | 4.33 |
| CHEMBL3409826 | — | — | 1 | 4.30 |
| CHEMBL1169729 | — | — | 1 | - |
| CHEMBL3409830 | — | — | 1 | - |
| CHEMBL3409832 | — | — | 1 | - |
| CHEMBL3409833 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL3409822 | — | IC50 | = | 11000.0 | nM | 4.96 |
| CHEMBL3409820 | — | IC50 | = | 21800.0 | nM | 4.66 |
| CHEMBL3409819 | — | IC50 | = | 23300.0 | nM | 4.63 |
| CHEMBL3409817 | — | IC50 | = | 25500.0 | nM | 4.59 |
| CHEMBL3409823 | — | IC50 | = | 25500.0 | nM | 4.59 |
| CHEMBL3409816 | — | IC50 | = | 26000.0 | nM | 4.58 |
| CHEMBL3407524 | — | IC50 | = | 26000.0 | nM | 4.58 |
| CHEMBL3409815 | — | IC50 | = | 28000.0 | nM | 4.55 |
| CHEMBL3409829 | — | IC50 | = | 30300.0 | nM | 4.52 |
| CHEMBL3409824 | — | IC50 | = | 31800.0 | nM | 4.50 |
| CHEMBL3409825 | — | IC50 | = | 31500.0 | nM | 4.50 |
| CHEMBL1414013 | — | IC50 | = | 35800.0 | nM | 4.45 |
| CHEMBL1718425 | — | IC50 | = | 35300.0 | nM | 4.45 |
| CHEMBL53463 | DOXORUBICIN | IC50 | = | 36300.0 | nM | 4.44 |
| CHEMBL3409836 | — | IC50 | = | 36500.0 | nM | 4.44 |
| CHEMBL3409818 | — | IC50 | = | 37000.0 | nM | 4.43 |
| CHEMBL3409821 | — | IC50 | = | 37800.0 | nM | 4.42 |
| CHEMBL3409827 | — | IC50 | = | 39300.0 | nM | 4.41 |
| CHEMBL3409828 | — | IC50 | = | 43300.0 | nM | 4.36 |
| CHEMBL3409831 | — | IC50 | = | 44800.0 | nM | 4.35 |
| CHEMBL3409834 | — | IC50 | = | 45300.0 | nM | 4.34 |
| CHEMBL3409835 | — | IC50 | = | 46300.0 | nM | 4.33 |
| CHEMBL3409826 | — | IC50 | = | 49800.0 | nM | 4.30 |
| CHEMBL1169729 | — | IC50 | - | — | - | |
| CHEMBL3409830 | — | IC50 | - | — | - | |
| CHEMBL3409832 | — | IC50 | - | — | - | |
| CHEMBL3409833 | — | IC50 | - | — | - |